Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (7)
  • Page (7)

Publication date

Selecting an option will change the focus to the start of the list.
  • April 2026 (2)
  • September 2024 (1)
  • June 2024 (1)
  • May 2023 (1)
  • March 2022 (1)
  • November 2020 (1)
  • February 2020 (2)
  • May 2019 (1)
  • January 2019 (1)
  • July 2017 (2)
  • July 2013 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • (-) Medical devices (9)
  • (-) Measles (5)
  • International (185)
  • COVID-19 (96)
  • International projects (64)
  • Nanotechnology and advanced materials (53)
  • Food safety (22)
  • Circular economy (20)
  • RIVM (20)
  • Soil and water (20)
  • Flu and flu vaccine (19)
  • Tobacco (17)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (17)
  • Alternatives to animal testing (15)
  • Antimicrobial resistance (15)
  • Behavioural science (15)
  • Consumer exposure to chemical substances (15)
  • Heat (15)
  • National Immunisation Programme (14)
  • Food and Nutrition (13)
  • Rubber granulate (13)
  • Sexually transmitted infections (STIs) (13)
  • Health research for COVID-19 (12)
  • Immunisation and vaccination (11)
  • Incidents and disasters (11)
  • Infectious Disease Control (11)
  • Mpox (11)
  • Occupational Safety (11)
  • Plastics (11)
  • Cervical cancer screening programme (10)
  • ConsExpo (10)
  • One Health (10)
  • PFAS (10)
  • Tick bites (10)
  • Dutch National Food Consumption Survey (9)
  • Public Health Foresight (9)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (9)
  • Zoonotic diseases (9)
  • Mental Health (8)
  • Tuberculosis (8)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (8)
  • WHO Collaborating Centre on Chemical Food Safety (8)
  • Pneumococci (7)
  • Respiratory infections (7)
  • Sustainability (7)
  • West Nile fever (7)
  • Mosquitos (6)
  • National Security (6)
  • Population screening programs in the Caribbean Netherlands (6)
  • Climate change and Health (5)
  • Food contact materials (5)
  • Healthy living environment (5)
  • Nitrogen (5)
  • Respiratory syncytial virus (RSV) (5)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (5)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Breast Cancer Screening Programme (4)
  • Dengue (4)
  • Endocrine disrupting chemicals (4)
  • Gonorrhoea (4)
  • HPV (4)
  • PIENTER Corona Study (4)
  • Population screening programmes (4)
  • Public Health Monitors (4)
  • Sustainable Development Goals (4)
  • Whooping cough (4)
  • Bird flu (avian influenza) (3)
  • Chromium (VI) and CARC (3)
  • Climate change (3)
  • DNA and public health (3)
  • Electromagnetic Fields (3)
  • Group A Strep infections (3)
  • Life Cycle Assessment (LCA) (3)
  • Lyme disease (3)
  • Malaria (3)
  • Meningococcal disease (3)
  • Physical Activity (3)
  • Tick-borne encephalitis (3)
  • UV index (3)
  • Wastewater research (3)
  • WHO Collaborating Centre for Immunotoxicology and Allergic Hypersensitivity; discontinued (3)
  • WHO Collaborating Centre for Nutrition (3)
  • Chikungunya (2)
  • Coronaviruses (2)
  • Ebola (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Legionella (Legionellosis) (2)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (2)
  • Livestock farming and health (2)
  • PFAS (2)
  • Probit functions (2)
  • Radiation and radioactivity (2)
  • Rubber tiles (2)
  • Salmonella (2)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (2)
  • Zika Virus (2)
  • Arboviruses (1)
  • Bestrijdingsmiddelen (1)
  • Chickenpox (1)
  • Contact (1)
  • Corona (1)
  • Digitale zorg (1)
  • Doetinchem Cohort Study (1)
  • Dutch Food Composition Database (NEVO) (1)
  • Environmental and industrial safety (1)
  • Exploratory study into environmental pollution and health on Bonaire (1)
  • Fipronil in eggs (1)
  • Global Health Security (1)
  • Health promotion (1)
  • Healthy City (1)
  • Heel prick (1)
  • Hepatitis A (1)
  • Hepatitis B (1)
  • HPV - Humaan Papillomavirus (1)
  • Lifestyle interventions (1)
  • Marburg virus disease (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • MERS (1)
  • NoroNet (1)
  • One Health (1)
  • Perinatal screening (1)
  • Pharmaceuticals in the environment (1)
  • Polio (1)
  • Rotavirus (1)
  • Scabies (1)
  • Shigellosis (1)
  • Shingles (1)
  • Synthetic biology (1)
  • WHO Collaborating Centre for Smallpox Vaccine (1)
  • WHO Collaborating Centre for the Family of International Classifications (FIC) (1)
  • WHO Collaborating Centre on Life Course and Health (1)

14 search results

You searched for these word(s): risk assessment
  • MEBI: risk of serious health complaints from Rebound HRD® inguinal hernia mesh

    https://www.rivm.nl/en/news/mebi-risk-of-serious-health-complaints-from-rebound-hrdr-inguinal-hernia-mesh

    … body for a long time, MEBI estimates there is a significant risk of other Rebound HRD® implants breaking in the longer … implants) to MEBI via the following website: rivm.nl/mebi . Risk of metal ring breaking An inguinal hernia mesh normally … for such a long time, MEBI estimates there is a significant risk of the metal wire breaking during the lifespan of the …

    Publication date: 06-25-2024
  • Shortcomings in the technical documentation of mesh implants intended to treat pelvic organ prolapse used in the Netherlands

    https://www.rivm.nl/en/news/shortcomings-in-technical-documentation-of-mesh-implants-intended-to-treat-pelvic-organ

    … After a detailed assessment of the technical documentation of nine different … are used to treat patients with pelvic organ prolapse. The assessment was commissioned by the Dutch Health and Youth … the technical documentation. This took place after the RIVM assessment had been completed.  Some of the manufacturers …

    Publication date: 03-21-2022
  • Mesh implants intended to treat pelvic organ prolapse

    https://www.rivm.nl/en/news/mesh-implants-intended-to-treat-pelvic-organ-prolapse

    … examining mesh implants in the laboratory. Technical file assessment Serious complications can occur upon transvaginal … prolapse. Therefore RIVM prioritized the technical file assessment of two transvaginal mesh implants that were still … the product, it means there are uncertainties about the risks. The manufacturers have been given the opportunity to …

    Publication date: 02-18-2020
  • Gastric balloons

    https://www.rivm.nl/en/medical-devices/gastric-balloons

    … causes the patient to eat less and lose weight. There are risks associated with the use of gastric balloons. RIVM has studied whether scientific research identified risks that are not currently stated on the instructions for … There are risks associated with the use of gastric balloons. The …

    Publication date: 09-19-2024
  • Measles and pregnancy

    https://www.rivm.nl/en/measles/pregnancy

    … measles and have never had measles themselves have a higher risk of severe illness due to measles. Read more about it … or they have ever been vaccinated against measles. Higher risk of severe disease Pregnant people who are not … measles and have never had measles themselves have a higher risk of severe illness due to measles, compared to people …

    Publication date: 04-13-2026
  • Injection needles

    https://www.rivm.nl/en/medical-devices/injection-needles

    … residues. RIVM investigated whether patients’ health was at risk through the use of these needles. …

    Publication date: 07-12-2017
  • Updated immunisation recommendation for measles: early vaccination before travel

    https://www.rivm.nl/en/news/updated-immunisation-recommendation-for-measles-early-vaccination-before-travel

    … vaccination for children between 6 and 14 months who are at risk Children usually receive an MMR vaccination at the age … Children between 6 and 14 months who have a major risk of contracting a measles infection are eligible for …

    Publication date: 05-01-2019
  • Summary International Expert Meeting on breast implant-associated lymphoma

    https://www.rivm.nl/en/news/summary-international-expert-meeting-on-breast-implant-associated-lymphoma

    … 2018, Dutch research was published that found an increased risk for ALCL in women with breast implants. ALCL is short …

    Publication date: 01-31-2019
  • Mesh implants intended to treat pelvic organ prolapse

    https://www.rivm.nl/en/medical-devices/mesh-implants-intended-to-treat-pelvic-organ-prolapse

    … were included in a report published by the IGJ (in Dutch). Assessment of technical documentation The IGJ commissioned … implants. Therefore, as a first step, RIVM completed its assessment of the technical documentation for the two … decided to share the results – provisional pending the full assessment of all selected mesh implants – directly with the …

    Publication date: 02-18-2020
  • Silicone breast implants

    https://www.rivm.nl/en/medical-devices/silicone-breast-implants

    … Breast implants and the risk of BIA-ALCL ALCL is a very rare form of lymphoma. Women … breast implants with a rough surface present an increased risk of BIA-ALCL. The Dutch Health and Youth Care …

    Publication date: 07-12-2017
  • Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

    https://www.rivm.nl/en/news/report-on-developments-of-national-immunisation-programme-national-immunisation-coverage

    … This vaccination is for children who are at greater risk of becoming seriously ill. A new study showed lower vaccine-effectiveness estimates for high-risk infants than expected. The ministry asked for a new …

    Publication date: 11-26-2020
  • Research

    https://www.rivm.nl/en/measles/research

    … schools in districts with a low vaccination coverage. The risk of measles in once-vaccinated children is very small … have some immunity. In addition, there is a relatively low risk of complications in children at the primary school age. …

    Publication date: 07-23-2013
  • Breast implants can cause health problems even five years or more after placement

    https://www.rivm.nl/en/news/breast-implants-can-cause-health-problems-even-five-years-or-more-after-placement

    … breast cancer and/or preventive removal due to genetic risk of breast cancer. Nature and number of health problems …

    Publication date: 05-25-2023
  • Measles at school or childcare

    https://www.rivm.nl/en/measles/at-school-or-childcare

    … how likely it is that others are infected. If there is a risk that your child may have contracted measles, the GGD …

    Publication date: 04-13-2026

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon